Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention
Executive Summary
Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
You may also be interested in...
First Day Children’s Multivitamin Needs ‘Good Fit’ Studies To Support Hyperactivity Claims
First Day Life discontinues claims its children’s multivitamin could help with attention issues and hyperactivity during a review by the National Advertising Division, which reminded the firm that studies in support of claims must not only be competent and reliable but also a “good fit.”
CRN Ends Funding For Industry Self-Regulation Program Focused On Supplement Advertising
The trade group ends funding for National Advertising Division program launched in 2006 for increased focus on monitoring supplement claims, reviewing 360 in total. Separately, NAD launches an expedited challenge process aiming to conclude reviews in 20 business days.
Doc of Detox Black Gold Supplement Tarnished Without Support For Claims
Doc of Detox Black Gold supplement claims for Alzheimer’s, cancer, diabetes, fatigue and heavy metal toxicity were reviewed in industry self-regulation forum. But Canadian firm International Institute of Health didn’t submit supporting evidence.